Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insulin sensitizers and heart failure: an engine flooded with fuel.

Literature DB >> 20963518

Insulin sensitizers and heart failure: an engine flooded with fuel.

Khaled I Khalaf¹, Heinrich Taegtmeyer.

Abstract

Entities: Chemical Disease Gene Mutation Species

Year: 2010 PMID： 20963518 PMCID： PMC3612890 DOI： 10.1007/s11906-010-0158-7

Source DB: PubMed Journal: Curr Hypertens Rep ISSN： 1522-6417 Impact factor: 5.369

× No keyword cloud information.

12 in total

1. The rise and fall of rosiglitazone.

Authors: Steven E Nissen
Journal: Eur Heart J Date: 2010-02-12 Impact factor: 29.983

2. Thiazolidinediones for type 2 diabetes. All glitazones may exacerbate heart failure.

Authors: A Benbow; M Stewart; G Yeoman
Journal: BMJ Date: 2001-01-27

Review 3. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

Authors: Steven E Nissen; Kathy Wolski
Journal: Arch Intern Med Date: 2010-07-26

4. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease.

Authors: D Jagasia; J M Whiting; J Concato; S Pfau; P H McNulty
Journal: Circulation Date: 2001-04-03 Impact factor: 29.690

5. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.

Authors: David Aguilar; Biykem Bozkurt; Kumudha Ramasubbu; Anita Deswal
Journal: J Am Coll Cardiol Date: 2009-07-28 Impact factor: 24.094

6. Effects of intensive glucose lowering in type 2 diabetes.

Authors: Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal: N Engl J Med Date: 2008-06-06 Impact factor: 91.245

Review 7. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.

Authors: Kamyar Kalantar-Zadeh; Gladys Block; Tamara Horwich; Gregg C Fonarow
Journal: J Am Coll Cardiol Date: 2004-04-21 Impact factor: 24.094

8. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Authors: Philip D Home; Stuart J Pocock; Henning Beck-Nielsen; Paula S Curtis; Ramon Gomis; Markolf Hanefeld; Nigel P Jones; Michel Komajda; John J V McMurray
Journal: Lancet Date: 2009-06-06 Impact factor: 79.321

Insulin sensitizers and heart failure: an engine flooded with fuel.

1. The rise and fall of rosiglitazone.

2. Thiazolidinediones for type 2 diabetes. All glitazones may exacerbate heart failure.

Review 3. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

4. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease.

5. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.

6. Effects of intensive glucose lowering in type 2 diabetes.

Review 7. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.

8. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

9. Utilization of energy-providing substrates in the isolated working rat heart.

10. Diet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle.

Review 1. After avandia: the use of antidiabetic drugs in patients with heart failure.

2. Metformin in Diabetic Patients with Heart Failure: Safe and Effective?